HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 1,129-1,140 of 1,979
Behavioral study icon
CompletedNCT00595387

Effectiveness of Cognitive Behavioral Therapy for Treating Depression in People With Bipolarity type I

What is this study about?

Researchers compared cognitive behavioural therapy and supportive therapy to find out how the approaches affected depression symptoms in people with bipolarity.

This study has finished and is no longer accepting participants.

In Boston
Bipolarity, DepressionInterventional studyAges 18–64
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Behavioral study icon
WithdrawnNCT03629106

Effects of Cannabis Abstinence on Symptomology and Cognition in Bipolarity

Official study title

Effects of Extended Cannabis Abstinence on Clinical and Cognitive Outcomes in Patients With Co-Morbid Bipolar Disorder and Cannabis Use Disorder

This study was withdrawn before enrollment.

In Toronto
Bipolarity, AddictionBehavioural studyAges 18–60
Countries
Canada
Sponsor
Centre for Addiction and Mental Health (Hospital / academic medical center)
Other study type icon
WithdrawnNCT01557933

Effects of Electroconvulsive Therapy (ECT) in Depression in bipolarity

Official study title

A Study of the Acute and Chronic Effects of Electroconvulsive Therapy on Glutamatergic Neurotransmission in Bipolar Depression

This study was withdrawn before enrollment.

Location not clearly listed
Bipolarity, DepressionObservational studyAges 18–55
Countries
Sponsor
Mclean Hospital (Hospital / academic medical center)
Other study type icon
CompletedNCT00216723

Aripiprazole for schizophrenia

Official study title

Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder

This study has finished and is no longer accepting participants.

In Seoul
Bipolarity, SchizophreniaObservational studyAges 18–80
Countries
South Korea
Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
Drug study icon
TerminatedNCT00771134

Lu AA39959 for depression in bipolarity

What is this study about?

Researchers are comparing Lu AA39959, placebo and Quetiapine to find out how the approaches affect depression symptoms in people with bipolarity type I or II.

This study ended early.

In Atlanta
Bipolarity, DepressionMedication studyAges 18–65
Countries
United States
Sponsor
H. Lundbeck A/S
Device study icon
TerminatedNCT02749006

Efficacy of rTMS in Depression in bipolarity

Official study title

A Randomized Double-blind Sham-controlled Trial of Repetitive Transcranial Magnetic Stimulation (rTMS) in Acute Bipolar Depression

This study ended early.

Multiple locations, including Calgary
Bipolarity, DepressionDevice studyAges 18–70
Countries
Canada
Sponsor
University of British Columbia
Drug study icon
CompletedNCT03965871

Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Depression in bipolarity

Official study title

A Multicentre, Double-blind, Randomised, Placebo - Controlled Phase II Study to Assess Efficacy, Safety and Pharmacokinetics of Inhaled Esketamine in Subject With Treatment-resistant Bipolar Depression

This study has finished and is no longer accepting participants.

Multiple locations, including Bełchatów
Bipolarity, DepressionMedication studyAges 18–65
Countries
Poland
Sponsor
Celon Pharma SA
Drug study icon
TerminatedNCT00464191

Escitalopram for depression in bipolarity

Official study title

Escitalopram in Bipolar Depression: a Placebo-controlled Study of Acute and Maintenance Treatment

This study ended early.

In Nordfjordeid
Bipolarity, DepressionMedication studyAges 18–70
Countries
Norway
Sponsor
Nordfjord Psychiatric Centre
Drug study icon
CompletedNCT01256177

Quetiapine Fumarate Extended Release for depression in bipolarity

Official study title

A Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar Depression

This study has finished and is no longer accepting participants.

Multiple locations, including Baoding
Bipolarity, DepressionMedication studyAges 18–65
Countries
China
Sponsor
AstraZeneca

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.